First Bank & Trust’s BridgeBio Pharma BBIO Stock Holding History

First Bank & Trust’s Portfolio BBIO Stock Details BBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$655K	Buy	8,797 +142	+2%	+$9.95K	0.1%	151
2026 Q1	$643K	Sell	8,655 -151	-2%	-$10.9K	0.1%	133
2025 Q4	$674K	Buy	8,806 +92	+1%	+$6.04K	0.11%	133
2025 Q3	$453K	Sell	8,714 -108	-1%	-$5.27K	0.08%	159
2025 Q2	$381K	Buy	8,822 +329	+4%	+$12K	0.07%	165
2025 Q1	$294K	Buy	8,493 +1,022	+14%	+$34.5K	0.06%	179
2024 Q4	$205K	Buy	+7,471	New	+$193K	0.04%	228
2024 Q3	–	Sell	-8,044	Closed	-$204K	–	235
2024 Q2	$204K	Buy	8,044 +13	+0.2%	+$355	0.04%	218
2024 Q1	$248K	Buy	+8,031	New	+$273K	0.05%	197

Other funds holding BBIO

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

QCM

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

CPBTD

Central Pacific Bank - Trust Division Honolulu, Hawaii $984M AUM 34.19% 1-Year Est. Return

CSP

Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return

LVW Advisors Pittsford, New York $1.16B AUM 26.37% 1-Year Est. Return

First Bank & Trust's BBIO Position: Q2 2026 in Review

First Bank & Trust increased its BridgeBio Pharma (BBIO) stake by 1.6% in Q2 2026, buying an estimated $9.95K and bringing the position to 8,797 shares worth $655K. The position accounts for 0.1% of the portfolio, ranked #151.

First Bank & Trust first reported a position in BBIO in Q1 2024 and has held it in 9 quarters since. The position peaked at $674K in Q4 2025. 40 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

First Bank & Trust held 8,797 shares of BridgeBio Pharma worth $655K as of Q2 2026.
First Bank & Trust bought 142 BridgeBio Pharma shares in Q2 2026, an estimated $9.95K.
BridgeBio Pharma made up 0.1% of First Bank & Trust's portfolio in Q2 2026, its #151 holding.
First Bank & Trust first reported a position in BridgeBio Pharma in Q1 2024 and has held it in 9 quarters since.
First Bank & Trust's BridgeBio Pharma position peaked at $674K in Q4 2025.
40 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on First Bank & Trust's 13F filing for Q2 2026, filed 9 Jul 2026.